AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Zero Based Budgeting For Families
Zero-based budgeting for families demonstrates collaborative budgeting and shared goals for better financial health.
16,890 articles
Alta Boosts XPEL Stake: A $58M Bet Expands 15.5% Position
Alta Fox quietly increases its XPEL exposure, lifting the stake to about 15.5% after a roughly $58 million purchase. ...
Revenue Divergence: Ethereum Activity Surges, Price Slumps
ETH activity climbs to record levels in Q1 2026 even as price declines and fees shrink. Analysts call it a classic re...
Best Aluminum Stocks Rise as Supply Tightens in 2026
Aluminum equities trade higher as supply discipline tightens and demand from aerospace and packaging stays resilient....
Intuitive Machines' Cash Grab: Not as Scary as It Seems
When Intuitive Machines announced a major equity raise, the stock sold off hard. But a disciplined look shows the mov...
Silver Crashing: Reasons Sell Now for Smart Investors
When markets swing, silver investors face tough choices. This article breaks down three clear reasons to consider sel...
MiCA Deadline Likely Shift Reshapes EU Crypto Rails
As the MiCA deadline approaches, smaller European crypto platforms face a choice between building a regulated stack o...
Altman Dario Amodei Refused Handshake at AI Summit
OpenAI CEO Sam Altman and Anthropic CEO Dario Amodei avoided a handshake at the India AI Impact Summit, signaling a w...
Temasek’s Moving Into Power: CFO Shakeup Reshapes Strategy
Temasek unveils a sweeping leadership overhaul, elevating its CFO into a central strategic role as the group reorgani...
Older Women Worry About Retirement Security, Study Finds
A new poll of voters 50+ shows persistent anxiety about retirement readiness among older women, with health costs and...
Forget SpaceX: Underpriced Space Stock Set for Rally
A space-focused Nasdaq-100 entrant is drawing attention after earnings and a key index promotion. Investors see a pot...
Forget Ozempic: This Obesity-Drug Giant Grabs GLP-1 Gold
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status